Tetrazine bicyclic compounds
US6313124A · kind A · utility
24Cited by
17References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 1998 |
| Grant date | Nov 6, 2001 |
| Priority date | — |
| Expiry date | Jan 28, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Corticotropin releasing factor (CRF) antagonists of formula I or II: ##STR1## and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.